Division of Cardiology, Kaiser Permanente Northern California, San Francisco, CA, USA.
Curr Atheroscler Rep. 2018 Jan 30;20(2):7. doi: 10.1007/s11883-018-0710-5.
We will review the available data on the epidemiology, pathophysiology, diagnosis, and management of microvascular coronary dysfunction (MCD).
The study of MCD was pioneered by the Women's Ischemia Syndrome Evaluation (WISE) cohort. New techniques in the diagnosis of this condition, using invasive and noninvasive means, are helping to increase awareness of this condition as well as ways in which to treat it. Microvascular coronary disease without epicardial involvement has become an increasingly recognized cause of cardiac chest pain, particularly in women. Dysfunction of the microvasculature related to endothelium-dependent and endothelial-independent factors likely results in symptoms and/or evidence of ischemia. Although there is a growing body of research, there is still much about MCD that we do not understand.
我们将回顾微血管性冠状动脉功能障碍(MCD)的流行病学、病理生理学、诊断和治疗方面的现有数据。
MCD 的研究由女性缺血综合征评估(WISE)队列开创。使用有创和无创手段诊断这种疾病的新技术正在帮助提高对这种疾病的认识,以及治疗这种疾病的方法。没有心外膜受累的微血管性冠状动脉疾病已成为心脏胸痛的一个日益被认可的原因,特别是在女性中。与内皮依赖性和内皮非依赖性因素相关的微血管功能障碍可能导致症状和/或缺血证据。尽管研究越来越多,但我们对 MCD 仍有许多不了解的地方。